Iran Press/ Iran news: The Sputnik-V vaccine has been authorized in more than 60 countries, including Iran. Actover Pharmaceutical Group has been selected as one of the first manufacturers of the vaccine in the Middle East.
The production capacity of the Sputnik-V vaccine in Actover company will be two million doses per month.
Following the accurate evaluation of the Actover biotechnology production lines by the Russian side, Actover pharmaceutical complex was selected as the center for the production of Sputnik V.
207/216
Read more:
Iran, Russia negotiate to produce COVID-19 vaccine jointly
